![Erythromycin ;Erythromycin A ;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione | 114-07-8](https://drjcrbio.com/wp-content/uploads/e-1.png)
Erythromycin ;Erythromycin A ;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione | 114-07-8
Description
| Code: JCERM-01 |
| CAS: 114-07-8 |
| Chemical Formula: C37H67NO13 |
| Molecular Weight: 733.93 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Erythromycin ;Erythromycin A ;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione | 114-07-8 is useful as reference Impurity standard. |
